Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05168657 · ClinicalTrials.gov registry record · NA
Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT05168657 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 54 participants.
The verdict
NCT05168657, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
This is a study assessing the feasibility of using the insulin-only configuration of the iLet bionic pancreas with initiation in pump-naïve people with type 1 diabetes in a primary care practice with either in-person training and follow-up (PC-IP) or with training and follow-up via telehealth (PC-TH). As a comparison, the iLet will be initiated by an academic endocrinology practice with either in-person training and follow-up (EN-IP) or with training and follow-up via telehealth (EN-TH).
Interventions
- OTHER Usual Care
- DEVICE Bionic Pancreas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2022-03-31 |
| Est. Completion | 2023-05-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05168657
The ClinicalTrials.gov registry entry for NCT05168657 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT05168657 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05168657 about?
NCT05168657 is a clinical study titled "Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth". This is a study assessing the feasibility of using the insulin-only configuration of the iLet bionic pancreas with initiation in pump-naïve people with type 1 diabetes in a primary care practice with either in-person training and follow-up (PC-IP) or with training and follow-up via telehealth (PC-TH...
What is the current status of trial NCT05168657?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2022-03-31. Estimated completion is 2023-05-23.
What interventions are being tested in trial NCT05168657?
The interventions under investigation include: Usual Care (OTHER), Bionic Pancreas (DEVICE).
Who is sponsoring clinical trial NCT05168657?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.